Delivery Order SPE2DB20D3505-SPE2DB24FT3E7
- Not listed
- This federal contract award is for the delivery of Moderna COVID-19 vaccine doses (0.25 mL) for the 6-month to 11-year-old age group under Emergency Use Authorization (EUA). The $1,476.88 firm-fixed-price Delivery Order was awarded to Amerisourcebergen Drug Corporation's Corporate Office Division by the Defense Logistics Agency (DLA), a major U.S. Department of Defense (DoD) agency responsible for providing logistics and acquisition support to the U.S. Armed Forces. Amerisourcebergen, a large...
- This federal contract award is for the delivery of Moderna COVID-19 vaccines (0.25 mL dose) for the 6-month to 11-year-old age group under the Emergency Use Authorization (EUA). The $12,800.00 firm-fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The contract has an ultimate completion date of January 23, 2024. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which...
- This contract award is for the delivery of Moderna COVID-19 vaccines (0.25 mL) for individuals aged 6 months to 11 years under the Emergency Use Authorization (EUA). The contract, valued at $3,797.30, was awarded by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. This is a firm fixed price delivery order contract that does not have a...
- This federal contract award is for the delivery of Moderna COVID-19 vaccines for individuals aged 6 months to 11 years, under a Delivery Order (DO) with a Firm Fixed Price (FFP) contract type. The contract was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., by the Defense Logistics Agency (DLA) Troop Support Medical, a defense agency responsible for supplying medical products to the U.S. military. The award has a ceiling value of $3,797.30 and an ultimate completion date...
- This federal contract award is for the delivery of 0.25 mL doses of the Moderna COVID-19 vaccine for the 6 month to 11 year old age group under the Emergency Use Authorization (EUA). The award, valued at $6,361.10, was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on November 1, 2024. The contract has a firm fixed price and an ultimate completion date of November 25, 2024. This appears to be a delivery order, likely part of a...
- This federal contract award, valued at $1,908.33, was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Moderna COVID-19 vaccines for the 6-month to 11-year-old age group under Emergency Use Authorization (EUA), with an ultimate completion date of November 12, 2024. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) valued at...
- This federal contract award, valued at $4,556.76, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company. The contract is for the delivery of Moderna COVID-19 vaccines for the 6-month to 11-year-old age group under the Emergency Use Authorization (EUA). This is a firm-fixed-price contract with a completion date of November 13, 2023. Amerisourcebergen holds two Indefinite Delivery Contracts (IDCs) with the federal government...
- This federal contract award is for the delivery of Moderna COVID-19 vaccines for children aged 6 months to 11 years old, under the Emergency Use Authorization (EUA). The contract, valued at $4,556.76, was awarded to Amerisourcebergen Drug Corp's Corporate Office Division by the Defense Logistics Agency (DLA), a defense agency. The contract is a Delivery Order with a Firm Fixed Price pricing type, and the ultimate completion date is November 6, 2023. The contract is not designated as a set-aside....
- This federal contract award is for the delivery of 0.25 mL doses of the Moderna COVID-19 vaccine for the 6-month to 11-year age group under the Emergency Use Authorization (EUA). The $1,290.00 firm fixed price delivery order was awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of December 30, 2024 and does not have a set-aside designation, indicating...
- This federal contract award, issued by the Defense Logistics Agency (DLA), was made to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide Moderna COVID-19 vaccine doses for the 6-month to 11-year-old age group under an Emergency Use Authorization. The $28,608.20 fixed-price delivery order contract has a completion date of July 9, 2024. This contract is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
- SPE2DB20D3505Indefinite Delivery Contract
- SPE2DB20D3505-SPE2DB24FT3E7Delivery Order
This federal contract award is for the delivery of Moderna COVID-19 vaccines for the 6-month to 11-year-old age group, under a Delivery Order (DO) placed against a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $25,283.10, was awarded by the Defense Logistics Agency (DLA) and has an ultimate completion date of November 28, 2023. Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc., is the prime contractor for this award. The company holds a significant $999,999,999 IDC with the DLA Troop Support Medical, which serves as the primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This award, which does not have a set-aside designation, is part of Amerisourcebergen's broader efforts to supply critical medical commodities, including specialty medications, brand-name and generic drugs, vaccines, and other medical supplies, to various federal government agencies and healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $25.3k | 11/3/23 |